In recent years, novel therapeutic interventions, such as vitamin D, angiotensin receptor blockers, inhibitors of myostatin, and anabolic steroids, have been proposed for counteracting sarcopenia in patients undergoing dialysis. The gene discussed is MSTN; the disease is sarcopenia.